Monoarticular Crystal Arthropathy of the Knee: Tophaceous Gout

Tophaceous gout is a crystal arthropathy and a disorder of purine metabolism characterized by monosodium urate crystal deposition. A case of tophaceous gout of the knee joint in a 30-year-old female is reported, and the imaging appearances on high-resolution ultrasonography are described. The patien...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Ravikanth Reddy
Formato: article
Lenguaje:EN
Publicado: Karger Publishers 2021
Materias:
R
Acceso en línea:https://doaj.org/article/fa7de4b6aad541078197d0dbc768b2b2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:fa7de4b6aad541078197d0dbc768b2b2
record_format dspace
spelling oai:doaj.org-article:fa7de4b6aad541078197d0dbc768b2b22021-11-11T10:40:46ZMonoarticular Crystal Arthropathy of the Knee: Tophaceous Gout2571-726X10.1159/000519571https://doaj.org/article/fa7de4b6aad541078197d0dbc768b2b22021-10-01T00:00:00Zhttps://www.karger.com/Article/FullText/519571https://doaj.org/toc/2571-726XTophaceous gout is a crystal arthropathy and a disorder of purine metabolism characterized by monosodium urate crystal deposition. A case of tophaceous gout of the knee joint in a 30-year-old female is reported, and the imaging appearances on high-resolution ultrasonography are described. The patient presented with complaints of insidious onset painless swelling of the left knee joint with limitation of range of movement for 1 week. The aspirated joint fluid demonstrated needle-like monosodium urate crystals showing strong negative birefringence consistent with a diagnosis of tophaceous gout. Targeted urate-lowering treatment included oral nonsteroidal anti-inflammatory drugs and oral colchicine. Prophylactic treatment for gout flare-ups included initiation of allopurinol at 300 mg/day along with modification of the dietary regimen including limited consumption of red meat and increased consumption of low-fat dairy products. Symptomatic improvement with reduced pain and swelling of the knee joint was noted at 10 days after treatment. Subsequently, at 3-month follow-up, the patient was disease free with no signs of recurrence and serum uric acid levels at 3.7 mg/dL. In spite of a wide range of therapeutic options available for the management of tophaceous gout, suboptimal management of gout is prevalent till date in both developing and developed nations across the world.Ravikanth ReddyKarger Publishersarticletophaceous goutfemale patienthigh-resolution ultrasonographyknee jointmonosodium urate crystalsMedicineRENDubai Medical Journal, Pp 1-5 (2021)
institution DOAJ
collection DOAJ
language EN
topic tophaceous gout
female patient
high-resolution ultrasonography
knee joint
monosodium urate crystals
Medicine
R
spellingShingle tophaceous gout
female patient
high-resolution ultrasonography
knee joint
monosodium urate crystals
Medicine
R
Ravikanth Reddy
Monoarticular Crystal Arthropathy of the Knee: Tophaceous Gout
description Tophaceous gout is a crystal arthropathy and a disorder of purine metabolism characterized by monosodium urate crystal deposition. A case of tophaceous gout of the knee joint in a 30-year-old female is reported, and the imaging appearances on high-resolution ultrasonography are described. The patient presented with complaints of insidious onset painless swelling of the left knee joint with limitation of range of movement for 1 week. The aspirated joint fluid demonstrated needle-like monosodium urate crystals showing strong negative birefringence consistent with a diagnosis of tophaceous gout. Targeted urate-lowering treatment included oral nonsteroidal anti-inflammatory drugs and oral colchicine. Prophylactic treatment for gout flare-ups included initiation of allopurinol at 300 mg/day along with modification of the dietary regimen including limited consumption of red meat and increased consumption of low-fat dairy products. Symptomatic improvement with reduced pain and swelling of the knee joint was noted at 10 days after treatment. Subsequently, at 3-month follow-up, the patient was disease free with no signs of recurrence and serum uric acid levels at 3.7 mg/dL. In spite of a wide range of therapeutic options available for the management of tophaceous gout, suboptimal management of gout is prevalent till date in both developing and developed nations across the world.
format article
author Ravikanth Reddy
author_facet Ravikanth Reddy
author_sort Ravikanth Reddy
title Monoarticular Crystal Arthropathy of the Knee: Tophaceous Gout
title_short Monoarticular Crystal Arthropathy of the Knee: Tophaceous Gout
title_full Monoarticular Crystal Arthropathy of the Knee: Tophaceous Gout
title_fullStr Monoarticular Crystal Arthropathy of the Knee: Tophaceous Gout
title_full_unstemmed Monoarticular Crystal Arthropathy of the Knee: Tophaceous Gout
title_sort monoarticular crystal arthropathy of the knee: tophaceous gout
publisher Karger Publishers
publishDate 2021
url https://doaj.org/article/fa7de4b6aad541078197d0dbc768b2b2
work_keys_str_mv AT ravikanthreddy monoarticularcrystalarthropathyofthekneetophaceousgout
_version_ 1718439183268184064